Malur, Karnataka, India, 4th October 2021
- First Indian Linear Accelerator to receive FDA 510(k) clearance
- Major milestone in the history of Indian Radiation Oncology
Panacea Medical Technologies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its next generation Stereotactic Body Radiotherapy (SBRT) enabled Linear Accelerator on a ring gantry platform.
“FDA clearance of Siddharth II is a crucial milestone in the deployment of the advanced technology machine for precision radiotherapy delivery while making it affordable for all”, said Mr. G V Subrahmanyam, Managing Director of Panacea. “This clearance is an important milestone to reach our aim of defeating cancer together across the globe”.
With its ring gantry design-Siddharth II, can deliver high end treatment techniques such as IGRT, IMRT, VMAT, and SBRT with sub millimeter accuracy. The system can deliver sophisticated treatment for various cancer cases in record time thereby increasing patient throughput for the clinics. The unit’s unique design enables it to be installed in any bunker with minimal modification. The system has an intuitive 4-step workflow for any treatment modality.
The affordable total cost of ownership of Siddharth II makes it an ideal solution for existing and upcoming radiation oncology facilities.
Panacea Medical Technologies Pvt. Ltd. is a world-leading manufacturer of advanced Radiation Oncology and Radiology equipment, pioneering state-of-the-art innovations and solutions for diagnosis and treatment of cancer. Panacea’s solutions are clinically advanced, cost efficient and patient centric.